Brookline Capital Acquisition Corp (BCAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCAC | AZN | AMGN | GILD | BMY |
| Company | Brookline Capital Acquisition Corp | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 10.07 | 90.14 | 325.58 | 123.80 | 54.52 |
| High | 27.74 | 91.12 | 330.82 | 126.24 | 54.91 |
| Low | 9.94 | 89.17 | 321.71 | 122.28 | 53.88 |
| Latest | 22.71 | 90.36 | 329.95 | 124.66 | 54.29 |
| Change | +12.63 | -4.03 | -0.46 | -0.25 | -0.97 |
| % Change | +125.30% | -4.27% | -0.14% | -0.20% | -1.76% |
| Volume | 586,400 | 8,133,503 | 1,390,254 | 4,741,154 | 6,698,293 |
| 20-Day Average Volume | 69,480 | 7,915,912 | 2,682,252 | 6,339,262 | 13,763,888 |
| Previous Close | 10.08 | 94.39 | 330.41 | 124.91 | 55.26 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.81 | 93.11 | 329.39 | 123.13 | 54.96 |
| 20-Day Raw Stochastic | 72.42% | 17.71% | 44.99% | 84.00% | 46.99% |
| 20-Day Relative Strength | 93.64 | 47.34 | 51.99 | 54.92 | 55.28 |
| Weighted Alpha | +26.80 | +32.16 | +20.27 | +31.74 | +0.18 |
| Today's Opinion | 100% Buy | 64% Buy | 56% Buy | 72% Buy | 80% Buy |
| Previous Opinion | 40% Buy | 100% Buy | 64% Buy | 72% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 72% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +130.09% since 07/22/22 | -3.37% since 01/12/26 | +1.18% since 01/12/26 | +2.55% since 01/12/26 | -2.46% since 01/12/26 |
| Low | 9.68 on 07/25/22 | 89.17 on 01/20/26 | 319.79 on 01/13/26 | 120.22 on 01/13/26 | 53.88 on 01/20/26 |
| High | 27.74 on 07/29/22 | 96.43 on 01/14/26 | 333.03 on 01/16/26 | 126.24 on 01/20/26 | 57.04 on 01/14/26 |
| 1-Month | |||||
| %Chg | +123.52% since 06/29/22 | -0.97% since 12/19/25 | +0.61% since 12/19/25 | +1.15% since 12/19/25 | +0.39% since 12/19/25 |
| Low | 9.50 on 07/22/22 | 89.17 on 01/20/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 27.74 on 07/29/22 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 57.04 on 01/14/26 |
| 3-Month | |||||
| %Chg | +124.52% since 04/29/22 | +7.87% since 10/20/25 | +8.59% since 10/20/25 | +2.12% since 10/20/25 | +24.80% since 10/20/25 |
| Low | 9.50 on 07/22/22 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 27.74 on 07/29/22 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| 6-Month | |||||
| %Chg | +127.10% since 01/28/22 | +31.52% since 07/18/25 | +11.75% since 07/18/25 | +16.18% since 07/18/25 | +14.86% since 07/18/25 |
| Low | 9.50 on 07/22/22 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 42.52 on 10/29/25 |
| High | 27.74 on 07/29/22 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 153,204 | 292,780,416 | 177,919,520 | 154,973,344 | 112,495,712 |
| Shares Outstanding, K | 6,746 | 3,101,816 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -480,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -2,457,658 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | -0.03 | 0.34 | 0.45 | 0.33 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 05/23/22 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 |
| Latest Earnings Date | 01/01/70 | 02/10/26 | 02/03/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.57 | 15.09 | 14.81 | 8.63 |